Details for Patent: 11,643,397
✉ Email this page to a colleague
Which drugs does patent 11,643,397 protect, and when does it expire?
Patent 11,643,397 protects JESDUVROQ and is included in one NDA.
This patent has thirty-six patent family members in thirty-one countries.
Drugs Protected by US Patent 11,643,397
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-001 | Feb 1, 2023 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | A METHOD OF TREATING ANEMIA | ⤷ Try a Trial | |||
Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-002 | Feb 1, 2023 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | A METHOD OF TREATING ANEMIA | ⤷ Try a Trial | |||
Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-003 | Feb 1, 2023 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | A METHOD OF TREATING ANEMIA | ⤷ Try a Trial | |||
Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-004 | Feb 1, 2023 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | A METHOD OF TREATING ANEMIA | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,643,397
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 061570 | ⤷ Try a Trial | |||
Australia | 2007260837 | ⤷ Try a Trial | |||
Brazil | PI0713446 | ⤷ Try a Trial | |||
Canada | 2655491 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |